相似文献
1
Recent Evidence on Advances in PCI Treatment for Left Main Coronary Artery Disease.
Rev Cardiovasc Med. 2022 Oct 31;23(11):370. doi: 10.31083/j.rcm2311370. eCollection 2022 Nov.
2
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Revascularization of Left Main Coronary Artery Disease.
Korean Circ J. 2023 Mar;53(3):113-133. doi: 10.4070/kcj.2022.0333.
3
Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials.
Eur Heart J. 2020 Sep 7;41(34):3228-3235. doi: 10.1093/eurheartj/ehaa135.
4
Long-term follow-up of percutaneous coronary intervention versus coronary artery bypass grafting in left main coronary artery disease: A systematic review and meta-analysis.
Catheter Cardiovasc Interv. 2021 Sep;98(3):427-433. doi: 10.1002/ccd.29338. Epub 2020 Oct 26.
5
New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.
J Am Coll Cardiol. 2018 Feb 20;71(7):739-748. doi: 10.1016/j.jacc.2017.12.012.
6
Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial.
JACC Cardiovasc Interv. 2018 Dec 24;11(24):2441-2450. doi: 10.1016/j.jcin.2018.09.008.
7
Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.
J Am Coll Cardiol. 2017 Dec 26;70(25):3113-3122. doi: 10.1016/j.jacc.2017.10.036. Epub 2017 Oct 30.
8
Five-year outcomes comparing percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in patients with left main coronary artery disease: A systematic review and meta-analysis.
Atherosclerosis. 2020 Sep;308:50-56. doi: 10.1016/j.atherosclerosis.2020.06.024. Epub 2020 Jul 4.
9
[Management of patients with left main stem stenosis in Iceland 2010-2020: PCI or CABG].
Laeknabladid. 2022 Sep;108(9):387-394. doi: 10.17992/lbl.2022.09.704.
10
Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes.
J Am Coll Cardiol. 2019 Apr 9;73(13):1616-1628. doi: 10.1016/j.jacc.2019.01.037.
本文引用的文献
1
Dual antiplatelet therapy after percutaneous coronary intervention for left main coronary artery disease.
Rev Esp Cardiol (Engl Ed). 2023 Apr;76(4):245-252. doi: 10.1016/j.rec.2022.07.007. Epub 2022 Jul 27.
2
The association of PRECISE-DAPT score with ischaemic outcomes in patients taking dual antiplatelet therapy following percutaneous coronary intervention: a meta-analysis.
Eur Heart J Cardiovasc Pharmacother. 2022 Aug 11;8(5):511-518. doi: 10.1093/ehjcvp/pvab080.
3
Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
Lancet. 2021 Dec 18;398(10318):2247-2257. doi: 10.1016/S0140-6736(21)02334-5. Epub 2021 Nov 15.
4
The invasive intracoronary imaging assessment of left main coronary artery disease.
Med Ultrason. 2022 May 25;24(2):218-225. doi: 10.11152/mu-3338. Epub 2021 Sep 11.
5
Radial Access for Coronary Angiography Carries Fewer Complications Compared with Femoral Access: A Meta-Analysis of Randomized Controlled Trials.
J Clin Med. 2021 May 17;10(10):2163. doi: 10.3390/jcm10102163.
6
The European bifurcation club Left Main Coronary Stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN).
Eur Heart J. 2021 Oct 1;42(37):3829-3839. doi: 10.1093/eurheartj/ehab283.
7
Clinical outcomes of the proximal optimisation technique (POT) in bifurcation stenting.
EuroIntervention. 2021 Dec 3;17(11):e910-e918. doi: 10.4244/EIJ-D-20-01393.
8
Long-Term Outcomes After PCI or CABG for Left Main Coronary Artery Disease According to Lesion Location.
JACC Cardiovasc Interv. 2020 Dec 28;13(24):2825-2836. doi: 10.1016/j.jcin.2020.08.021.
9
The EXCEL Trial: The Surgeons' Perspective.
Eur Cardiol. 2020 Nov 9;15:e67. doi: 10.15420/ecr.2020.34. eCollection 2020 Feb.
10
Optical coherence tomography to guide percutaneous coronary intervention of the left main coronary artery: the LEMON study.
EuroIntervention. 2021 Jun 11;17(2):e124-e131. doi: 10.4244/EIJ-D-20-01121.
Zotero 插件